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E synthase-1; MVD, microvessel density; PGE2, prostaglandin E2; PPARδ, 
Peroxisome proliferator-activated receptor δ; RT-PCR, reverse-transcribed 
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Abstract 
Background & Aims:  Accumulating evidence indicate that prostaglandin E2 (PGE2), 
a downstream product of cyclooxygenase 2 (COX-2), plays a key role in gastric 
tumorigenesis.  The Wnt pathway is also suggested to play a causal role in gastric 
carcinogenesis.  However, the molecular mechanism remains poorly understood 
how the Wnt and PGE2 pathways contribute to gastric tumorigenesis.  To investigate 
the role of Wnt and PGE2 in gastric cancer, we have generated transgenic mice that 
activate both pathways, and examined their phenotypes.  Methods:  We constructed 
K19-Wnt1 transgenic mice expressing Wnt1 in the gastric mucosa using the keratin 
19 promoter.  We then crossed K19-Wnt1 mice with another transgenic line 
K19-C2mE to obtain K19-Wnt1/C2mE compound transgenic mice.  The K19-C2mE 
mice express COX-2 and microsomal prostaglandin E synthase-1 (mPGES-1) in the 
stomach, showing an increased gastric PGE2 level.  We examined the gastric 
phenotypes of both K19-Wnt1 and K19-Wnt1/C2mE mice.  Results: K19-Wnt1 mice 
had a significant suppression of epithelial differentiation, and developed small 
preneoplastic lesions consisting of undifferentiated epithelial cells with macrophage 
accumulation.  Importantly, additional expression of COX-2 and mPGES-1 
converted the preneoplastic lesions in the K19-Wnt1 mice into dysplastic gastric 
tumors by 20 weeks of age.  Notably, we found mucous cell metaplasia in the 
glandular stomach of the K19-Wnt1/C2mE mice as early as 5 weeks of age, before 
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the dysplastic tumor development.   Conclusions:  Wnt signaling keeps the gastric 
progenitor cells undifferentiated.  Simultaneous activation of both Wnt and PGE2 
pathways causes dysplastic gastric tumors through the metaplasia-carcinoma 
sequence.   
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Introduction 
The binding of Wnt ligands to a Frizzled receptor destabilizes the β-catenin 
degradation complex containing APC, thereby allowing the nuclear translocation of 
β-catenin followed by transcriptional activation of the Wnt target genes1.  The constitutive 
activation of the Wnt pathway by mutations in either the Apc or β-catenin gene results in 
intestinal polyposis2,3.  Nuclear localization of β-catenin, a hallmark of Wnt activation, is 
found also in about 30% of gastric cancer tissues4, suggesting that Wnt pathway activation is 
one of the major causes of gastric carcinogenesis.  However, there is few genetic evidence for 
Wnt activation in gastric cancer. 
Epidemiological evidence shows that Helicobacter pylori infection is associated with 
gastric cancer5.  We recently demonstrated that an infection of mice with Helicobacter felis, a 
close relative of H. pylori, induces expression of both cyclooxygenase-2 (COX-2) and 
microsomal prostaglandin E synthase-1 (mPGES-1) in the gastric mucosa6.  Inducible 
enzyme COX-2 catalizes biosynthesis of prostaglandin (PG)H2, which is further converted to 
PGE2 by mPGES-17.  Expression of both COX-2 and mPGES-1 is also induced in a variety 
of cancer tissues8.  It is established that COX-2 plays a key role in gastrointestinal cancer 
development9, and inhibition of COX-2 in mouse models by selective inhibitors suppresses 
gastric and intestinal tumorigenesis10,11.  Furthermore, PGE2 is also implicated in 
gastrointestinal tumor development12,13.  Accordingly, it is essential for gastric tumorigenesis 
to increase the level of PGE2 through induction of COX-2 and mPGES-1. 
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However, the cooperation of Wnt signaling and the PGE2 pathway has not yet been 
investigated in gastric tumorigenesis.  In this study, we have constructed transgenic mice 
expressing Wnt1 in the gastric mucosa, and examined epithelial proliferation and 
differentiation.  We then introduced COX-2 and mPGES-1 genes into the Wnt1 transgenic 
mice by crossing with the other transgenic line, and studied the changes in the gastric lesions.  
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Materials and Methods 
Tissue samples 
In total, 80 patients were pre-operatively diagnosed with sporadic gastric cancer (47 
intestinal-type and 33 diffuse type) in 1998-1999 at Kanazawa University Hospital, Japan.  
Any patients with signet ring cell carcinoma were excluded because of the difficulty in 
evaluating nuclear β-catenin staining.  All experiments were carried out according to the 
protocol approved by the Ethics Committee of Kanazawa University.  Informed consent was 
obtained from all participants. 
Transgenic mice 
The K19 promoter with a synthetic intron and SV40 poly(A) cassette were described 
previously6.  Although the K19 promoter used in the present study is transcriptionally active 
in the gastric epithelium, its expression spectrum in the whole body is slightly different from 
the endogenous K19 gene possibly caused by the limited length of the promoter fragment6.  
Wnt1 cDNA was excised from pUSEamp-Wnt1 (Upstate, Charlottesville, VA).  These 
fragments were cloned into pBluescript (Stratagene, La Jolla, CA) to construct the 
pK19-Wnt1 transgenic vector.  The expression vector was microinjected into the fertilized 
eggs of F1 (C3H and C57BL/6) hybrid females crossed with C57BL/6 males to generate 
K19-Wnt1 transgenic mice.  Expression of Wnt1 in the gastric mucosa was confirmed by 
RT-PCR.  Construction of K19-C2mE transgenic mice has been described previously6.  To 
minimize any genetic background differences, we used littermate mice for the experiments 
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from the mating of N2-backcrossed K19-Wnt1 with N6-backcrossed K19-C2mE mice.  
Backcrossing was performed using wild-type C57BL/6 mice.  Construction of ApcΔ716 mice 
has been previously described2.  All animal experiments were carried out according to the 
protocol approved by the Ethics Committees on Animal Experimentation of Kyoto 
University and Kanazawa University. 
Histology and immunohistochemistry 
Tissues were fixed in 4% paraformaldehyde, embedded and sectioned at 4-μm 
thickness.  Sections were stained with H&E or Alcian blue at pH 2.5.  To detect nuclear 
β-catenin, mouse monoclonal antibody for the stabilized (active) form of β-catenin (Clone 
8E7, Upstate, Charlottesville, VA) was used as the primary antibody after autoclaving the 
sections for 20 min in sodium citrate buffer (pH 6.0).  This antibody is specific for the active 
form of human and mouse β-catenin, dephosphorylated on Ser37 or Thr41.  To detect total 
β-catenin, polyclonal anti-β-catenin antibody (Sigma, St. Louis, MO) was used.  This 
antibody reacts with human and mouse β-catenin peptide corresponding to amino acids 
768-781.  For the cell proliferation analysis, monoclonal rat anti-mouse Ki-67 antibody 
(Clone TEC-3, DakoCytomation, Carpinteria, CA) was used.  This antibody is specific for 
the mouse Ki-67, a nuclear protein expressed during all phases of the cell cycle (G1, S, G2 and 
M phases).  To detect macrophages, rat monoclonal anti-mouse F4/80 anibody (MCA497R; 
Clone A3-1, Serotec, Oxford, UK) was used.  This antibody recognizes the mouse F4/80 
antigen expressed by macrophages.  To detect capillary vessels, polyclonal anti-von 
 8
Oshima, H. et al. 
Willebrand Factor (vWF) antibody (DakoCytomation, Carpinteria, CA) was used.  This 
antibody reacts with endothelial cells.  The MOM Kit  (Vector Laboratories, Burlingame, 
CA) was used to minimize the background staining signals.  Staining signals were visualized 
using the Vectorstain Elite Kit (Vector Laboratories, Burlingame, CA).   
BrdU labeling index 
Mice were injected i.p. with 200 μl of BrdU solution (BD Pharmingen, San Diego, 
CA) at 30 min before euthanasia.  Tissue samples were fixed in 4% paraformaldehyde, 
embedded and sectioned at 4-μm thickness.  These sections were stained with anti-BrdU 
antibody (BD Pharmingen).  The number of BrdU-positive cells per gland (Fig. 3E) or 
microscopic field (Fig. 8) was calculated as the BrdU labeling index.  BrdU positive cells 
were counted in 5 high-powered fields. 
In situ hybridization 
Rehydrated paraffin sections were digested with 5 μg/ml of proteinase K, hybridized 
overnight with 500 ng/ml of riboprobe, and then were stringently washed in 2 × SSC/50% 
formamide, followed by 0.1 × SSC.  The anti-sense and sense riboprobes were labeled using 
digoxigenin-labeling reagent (Roche Diagnostics, Indianapolis, IN).  The sense probe was 
used as a negative control (data not shown). 
Scoring Preneoplastic Lesions 
After fixation with 4% paraformaldehyde for 20 min, stomach tissue were stained 
with 0.05% toluidine blue solution for 30 min, and then the total number of preneoplastic 
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lesions in the glandular stomach were scored using a dissecting microscope.   
Scoring Microvessel Density (MVD). 
MVD was determined using histological sections immunostained with anti-vWF 
antibody.  The microscopic field that contained the highest number of capillaries was chosen 
for each sample by an initial scan at a low-magnification (×100).  Then, the vessels were 
counted in high-magnification fields (×400).  At least, 5 microscopic fields for each genotype 
were scored.  Relative MVD was calculated by dividing the mean number of each MVD with 
the mean value of the wild-type MVD. 
Immunoblotting Analysis 
The tissue samples were homogenized and sonicated in lysis buffer.  After 
centrifugation at 2,000 × g, 10 μg of the supernatant protein was separated in a 10% 
SDS-polyacrylamide gel.  Antibodies for unphosphorylated β-catenin (Upstate, 
Charlottesville, VA), total β-catenin (Sigma, St. Louis, MO), and COX-2 (Cayman Chemical, 
Ann Arbor, MI) were used as the primary antibody.  The ECL detection system (Amersham 
Biosciences, Buckinghamshire, UK) was used to detect the specific signals. 
Statistical Analysis 
Data were analyzed by the unpaired t-test using Microsoft Excel 2004 (Microsoft), 
and presented as the mean ± standard deviation (s.d.).  A value of P < 0.05 was accepted as 
statistically significant. 
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Results 
Activation of the Wnt Pathway in Human Gastric Cancer Tissues 
We first examined 80 cases of gastric cancer (47 and 33 cases for the intestinal type 
and diffuse type, respectively) by immunohistochemistry (Figure 1).  The nuclear 
localization of β-catenin was detected in 24 and 19 cases of intestinal-type and diffuse type 
gastric cancer, respectively, whereas β-catenin was found in the basolateral membrane of the 
adjacent normal tissues of the same patients (Figure 1B, C, E and F).  These results suggest 
that the Wnt pathway is activated in 54% of the gastric cancer tissues examined (Figure 1G), 
and that Wnt signaling plays a causal role in gastric carcinogenesis.   
Construction of K19-Wnt1 Transgenic Mice 
To further investigate the genetic mechanism of Wnt signal activation in gastric 
carcinogenesis, we constructed transgenic mice (K19-Wnt1) that express Wnt1 in the gastric 
epithelial cells using cytokeratin19 (K19) gene promoter (Figure 2A).  We used the Wnt1 
cDNA for transgenic expression because Wnt1 is one of the Wnt ligands in the canonical Wnt 
pathway.  We confirmed the expression of Wnt1 in the constructed K19-Wnt1 mouse stomach 
by RT-PCR (Figure 2B), although Wnt1 was not detected in the wild-type gastric mucosa.  The 
levels of unphosphorylated (active form) β-catenin increased significantly in the Wnt1 
transgenic mice (lines #1 through #5) compared with that in the wild-type mice (Figure 2C), 
indicating activation of the canonical Wnt pathway in the transgenic mouse gastric mucosa.  
Notably, the level of unphosphorylated β-catenin in the K19-Wnt1 mice (lines #1 and #2) was 
 11
Oshima, H. et al. 
similar to that in ApcΔ716 mouse intestinal polyps where the canonical Wnt pathway was 
activated by the loss of the wild-type Apc gene2.  Because these two transgenic lines, #1 and 
#2, showed essentially the same phenotypes, we present here the results of line #2 (hereafter 
called: K19-Wnt1). 
Suppression of Gastric Epithelial Differentiation by Wnt Activation 
Given that Wnt signaling is essential for maintaining the intestinal crypt that contains 
epithelial progenitor cells and stem cells14,15, we examined gastric epithelial differentiation in 
the K19-Wnt1 mice.  The trefoil factor 2 (TFF2) was used as an undifferentiated epithelial 
marker, because it was detected in the small isthmal cells (Figure 3A and B) where β-catenin 
accumulated in both the nucleus and cytoplasm (Figure 3C).  Among these small isthmal 
cells, gastric progenitor cells and granule-free stem cells exist16.  Notably, we found that the 
TFF2-expressing cell population expanded to the upper gland in the K19-Wnt1 mouse 
stomach, although it was limited to the isthmus in the wild type (Figure 3D).  The number of 
TFF2-positive cells was twice as high in the K19-Wnt1 mice as in the wild-type mice.  
Moreover, the number of BrdU incorporating cells with 30-minute labeling was 1.6-fold 
higher in the K19-Wnt1 gastric mucosa than in wild type (Figure 3E).  Most BrdU-labeled 
cells within 30 minutes are considered to be gastric progenitor cells16.  Consistently, the 
K19-Wnt1 mice contained 1.5 times more Ki-67-positive cells than the wild type (Figure 3F).  
These results indicate that Wnt signaling activation causes expansion of the undifferentiated 
progenitor cell population in the glandular stomach. 
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Preneoplastic Lesions in the K19-Wnt1 Mouse Glandular Stomach 
In the glandular stomach of the K19-Wnt1 mice, we found limited numbers of small 
lesions from 7 weeks of age as thickened mucosal foci under a dissecting microscope (Figure 
4B).  The mean number of 37 such lesions in the whole glandular stomach at 18 weeks of age 
was significantly higher than 4.5 at 7 weeks (n=3 for each age), whereas no such lesions 
existed in the wild-type mice (Figure 4A and C).  Histologically, the lesion contained 
undifferentiated epithelium consisting of small isthmal cells with irregular branching (Figure 
4D).  We found increased proliferation rates of epithelial cells by Ki-67 immunostaining 
(Figure 4E), and β-catenin accumulation in the undifferentiated epithelial cells (Figure 4F).  
Accordingly, these preneoplastic lesions consisted of Wnt-activated epithelial cells.   
Dysplastic Gastric Tumors Caused by the Cooperation of the Wnt and PGE2 
Pathways 
We then examined whether PGE2 produced by the activation of COX-2 and 
mPGES-1 contributes to Wnt-dependent gastric carcinogenesis.  We crossed K19-Wnt1 mice 
with another transgenic line (K19-C2mE6) that expresses both COX-2 and mPGES-1 in the 
gastric mucosa, and generated compound transgenic line K19-Wnt1/C2mE.  We confirmed 
large amounts of COX-2 protein in the stomach of both K19-C2mE and K19-Wnt1/C2mE 
mice (Figure 2D) and lack of Wnt1 expression in the K19-C2mE gastric mucosa (Figure 2B).  
Notably, Wnt1 expression in the K19-Wnt1/C2mE mouse stomach increased significantly 
compared with that in the K19-Wnt1 mice (Figure 2B).  This may be caused by increased 
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number of Wnt1-expressing undifferentiated cells in the K19-Wnt1/C2mE stomach (see 
below).  Importantly, we found large tumors associated with hyperemia in the 
K19-Wnt1/C2mE mice at 30 weeks of age (Figure 5B).  No such tumors were found in either 
K19-Wnt1 or K19-C2mE mice (Figure 5C and D), although mucosal hyperplasia developed 
in the K19-C2mE mice in the proximal glandular stomach as we reported previously6 (Figure 
5D).  The hyperplasia in the K19-C2mE mice consisted of the TFF2-expressing metaplastic 
mucous cells, i.e., spasmolytic polypeptide (TFF2)-expressing metaplasia (SPEM)17. 
Histologically, the gastric tumors in the K19-Wnt1/C2mE mice consisted of 
dysplastic epithelial cells with nuclear stratification and irregularly branched tubules (Figure 
5B and E).  The tumor epithelial cells had nuclear accumulation of β-catenin (Figure 5F).  We 
also found increased Ki-67 labeling, indicating an increased proliferation of tumor cells 
(Figure 5G).  These histological characteristics resembled those of human intestinal-type 
gastric cancer (Figure 1A and B).  Furthermore, we found TFF2-expressing SPEM also 
adjacent to the dysplastic tumor tissue of the K19-Wnt1/C2mE mice (Figure 5H), showing a 
similar histology to human gastric adenocarcinoma18.  Tumor invasion into the smooth 
muscle layers were also found in the 50, 75 and 100% of the K19-Wnt1/C2mE mice at 20, 30 
and 50 weeks of age, respectively (Figure 5I and J).  The incidence of dysplastic gastric 
tumors was 100% in the K19-Wnt1/C2mE mice older than 20 weeks of age (Figure 5K).  Five 
of them became moribund between 25 and 50 weeks of age (data not shown).  These results 
collectively indicate that the simultaneous activation of the Wnt and PGE2 pathways causes 
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development of dysplastic gastric tumors by their synergistic effects.  We did not find any 
metastatic tumors in other tissues including lymph nodes, liver, lung and peritoneum.   
Macrophage Accumulation in Dysplastic Tumors and Preneoplastic Lesions 
Tissue macrophages are implicated in the proliferation of epithelial progenitor cells in 
the intestine19.  We thus examined macrophage infiltration in the respective mutant mice by 
immunostaining.  We found abundant macrophages in the large gastric tumors of the 
K19-Wnt1/C2mE mice, whereas tissue macrophages were sparsely scattered in the wild-type 
glandular stomach (Figure 6A and B).  This is consistent with the previous results that 
macrophages are accumulated in the gastric mucosa of the simple K19-C2mE transgenic 
mice, probably caused by increased PGE2 and chemokine signaling6.  It is worth noting that 
macrophages accumulated also in the small preneoplastic lesions of the K19-Wnt1 mice 
(Figure 6C).  These results suggest that macrophages play an important role in the 
Wnt-dependent preneoplastic and neoplastic changes, possibly through secreting growth 
factors and cytokines like tumor associated macrophages20.   
Increased Angiogenesis in the K19-Wnt1/C2mE Tumors  
We have previously shown that PGE2 signaling is important for angiogenesis in the 
intestinal tumorigenesis21.  We thus examined angiogenesis in the K19-Wnt1 and 
K19-Wnt1/C2mE mouse stomach by immunostaining using an anti-vWF antibody, and 
determined relative microvessel density (MVD).  Although MVD in the K19-Wnt1 gastric 
mucosa stayed at the same level as that in the wild-type mice, it increased significantly in the 
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K19-Wnt1/C2mE tumors (Figure 6D-F).  Accordingly, it is possible that PGE2 signaling 
contributes to gastric tumor development through stimulation of angiogenesis as well as 
macrophage recruitment in the Wnt-activated gastric mucosa. 
Gastric Tumorigenesis through Metaplasia-Carcinoma Sequence in 
K19-Wnt1/C2mE Mice 
To understand the histopathogenesis of gastric tumor development, we examined the 
K19-Wnt1/C2mE and K19-C2mE mice chronologically at 5, 10, 20 and 50 weeks of age 
(Figure 7A-P).  The K19-Wnt1/C2mE mice showed mucous metaplasia with Alcian-blue 
positive cells at 5 weeks of age, the same phenotype as in the K19-C2mE mice (Figure 7A, E, 
I and M).  In the wild-type mouse gastric mucosa, weak Alcian-blue staining was detected 
only in the mucous neck cells (Figure 7E right).  We also found dysplastic tumor cells (Alcian 
blue negative) in the metaplastic lesion of the K19-Wnt1/C2mE, but not in the K19-C2mE 
mice at 10 weeks of age (Figure 7B, F, J and N).  The number of the dysplastic cells increased 
with age, and the mucous cells were found adjacent to the dysplastic tumors at 20 weeks of 
age (Figure 7C and G).  These histological characteristics were consistent with the finding 
that SPEM was found adjacent to the dysplastic tumors at 30 weeks of age (Figure 5H).  By 
50 weeks of age, dysplastic tumor cells predominated the tumors of the K19-Wnt1/C2mE 
mice (Figure 7D and H).  In contrast, no dysplastic signs were found in the K19-C2mE mice 
even at 50 weeks of age (Figure 7L and P).  These results indicate that the increased PGE2 
level caused epithelial metaplasia to the SPEM lineage, and that simultaneous activation of 
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the Wnt and PGE2 pathways causes development of dysplastic gastric tumors through 
metaplasia stage. 
Increased Proliferation by the Activation of Wnt and PGE2 Pathways 
We next determined the proliferation rates of normal and tumor epithelial cells by 
BrdU incorporation assays (Figure 8).  The BrdU labeling index in the stomach of both 
K19-Wnt1/C2mE and K19-C2mE mice was stomach significantly higher than in the 
wild-type mice from 5 weeks of age.  Thus, increased PGE2 signaling appears to be 
responsible for the hyperproliferation of gastric epithelial cells.  Furthermore, 
K19-Wnt1/C2mE mice showed even higher labeling index than the K19-C2mE mice after 20 
weeks of age, suggesting that simultaneous activation of both Wnt and PGE2 pathways may 
thus lead the epithelial cells to further epithelial cell proliferation.  This interpretation is 
consistent with the increased number of proliferating dysplastic cells in the K19-Wnt1/C2mE 
stomach.  
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Discussion 
Wnt signaling plays an important role in the maintenance of the intestinal crypt 
containing the stem cells and undifferentiated progenitor cells14,15.  In the gastric gland, Wnt 
signaling also keeps the progenitor cells undifferentiated in the isthmus of the gastric gland, 
as we have shown that the number of progenitors increased significantly in the K19-Wnt1 
mouse stomach.  It has been reported that Wnt signal activation was found in 30% of the 
human gastric cancer examined4.  In the present study, we have found nuclear accumulation 
of β-catenin in 54% of the gastric cancer tissues examined.  The high frequency of Wnt 
signal activation is likely due to the improved staining method and use of the specific 
antibody for the unphosphorylated and therefore stabilized form of β-catenin (see Materials 
and Methods).  Accordingly, our results suggest that Wnt signaling is one of the major causes 
of gastric carcinogenesis regardless of the histological type.  On the other hand, the COX-2 
pathway has been demonstrated to play a key role in a variety of cancers including gastric 
tumorigenesis9-13.  Therefore, it is possible that both Wnt signaling and the COX-2 pathway 
are activated simultaneously in some human gastric cancers.  We have presented genetic 
evidence for such simultaneous activation of the Wnt and PGE2 pathways in gastric 
carcinogenesis.  On the other hand, we did not find any preneoplastic lesions or tumors in the 
stomach of the ApcΔ716 mice that is a model for familial adenomatous polyposis (data not 
shown).  In the ApcΔ716 mice, somatic loss of the wild-type Apc gene is required for Wnt 
activation2, whereas Wnt1 is constitutively expressed in the K19-Wnt1/C2mE mouse 
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stomach.  Accordingly, it is possible that the frequency of simultaneous induction of both 
Wnt and PGE2 pathways is considerably low in the ApcΔ716 mouse gastric mucosa, and this 
may explain the absence of gastric tumors. 
Epidemiologic evidence indicates that Helicobacter pylori infection contributes to 
gastric carcinogenesis5.  We recently demonstrated that infection of mice with H. felis, a 
close relative of H. pylori, induces both COX-2 and mPGES-1 in the gastric mucosa, raising 
the PGE2 level as in the K19-C2mE mice6.  Accordingly, it is possible that Wnt activation 
through a mutation in APC or β-catenin in the H. pylori-infected stomach imposes in an 
increased risk of gastric carcinogenesis by the synergistic effects of the Wnt and PGE2 
pathways. 
We previously showed that an increased PGE2 level by simultaneous expression of 
COX-2 and mPGES-1 causes gastric hyperplasia with mucous cell metaplasia to the SPEM 
lineage17.  Gastric metaplasia to the SPEM lineage has a strong association with human 
gastric adenocarcinoma and is considered as a precursor of gastric cancer18,22.  As anticipated, 
the K19-Wnt1/C2mE mice developed mucous metaplasia at 5 weeks of age with a similar 
histology to SPEM in the K19-C2mE mice.  Importantly, we found dysplastic tumor cells in 
the metaplastic lesions in 10- to 30-week-old mice, respectively, with the SPEM adjacent to 
the dysplastic tumors.  These results are consistent with the interpretation that dysplastic 
gastric tumors are derived from the SPEM by activation of both the Wnt and PGE2 pathways.  
Therefore, the K19-Wnt1/C2mE model can be a useful tool to study molecular pathogenesis 
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of the gastric cancer through metaplasia-carcinoma sequence. 
We found accumulated macrophages in the preneoplastic lesion of the K19-Wnt1 
mice.  Tissue macrophages are important component of intestinal progenitor niche19.  
Moreover, tumor associated macrophages play an important role in tumor growth through 
secretion of cytokines, chemokines and growth factors20.  Consistently, we have shown that 
accumulation and activation of macrophages in the K19-C2mE mouse stomach are 
responsible for gastric metaplasia and hyperplasia6,17.  Accordingly, it is possible that 
accumulated macrophages cooperate with Wnt pathway activation in the development of 
preneoplastic lesions in the K19-Wnt1 mice.  The molecular mechanisms that recruit 
macrophages remain to be investigated further.  We have previously reported that 
PGE2-dependent angiogenesis is one of the key factors for intestinal polyp development21.  
Here, we found that angiogenesis is also stimulated in the K19-Wnt1/C2mE tumors.  
Accordingly, it is possible that PGE2 signaling contributes gastric tumorigenesis through 
angiogenesis as well as macrophage activation. 
Recently, crosstalk has been reported between Wnt signaling and COX-2 pathway23.  
Peroxisome proliferator-activated receptor δ (PPARδ) is one of the Wnt target genes.  The 
PGE2 signaling accelerates growth of intestinal adenomas, which is suppressed by inhibition 
of PPARδ.  These results suggest that PPARδ is a focal point of the crosstalk between the 
Wnt and PGE2 pathways.  Another line of evidence shows that PGE2 signaling through EP2 
receptor releases GSK-3β from β-catenin degradation complex and phosphorylates GSK-3β 
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through activation of PI3K/Akt24.  Consequently, β-catenin is stabilized, and Wnt signaling is 
activated.  To further investigate the molecular changes responsible for the crosstalk between 
Wnt and PGE2 signaling, we examined the microarray expression profiles in the glandular 
stomach of the K19-C2mE and wild-type mice (GEO database; accession number, GSE3903).  
Because K19-Wnt1/C2mE mice but not K19-Wnt1 mice develop gastric tumors, we expect 
that some of the upregulated molecules in the K19-C2mE mice are such candidates, and 
possible new targets for the prevention and treatment of gastric cancer. 
In conclusion, simultaneous activation of the Wnt signaling and PGE2 pathway can 
cause gastric carcinogenesis.  Our compound transgenic mouse strain K19-Wnt1/C2mE is a 
genetic model for gastric carcinogenesis in the metaplasia-carcinoma sequence, and may be a 
useful tool to study the molecular pathology of, and development of therapeutic drugs for 
gastric cancer. 
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Figure Legends 
Figure 1 
Nuclear localization of β-catenin in human gastric cancer.  Representative histological 
sections (H&E) of intestinal-type (A) and diffuse type (D) gastric cancer.  
Immunostaining for unphosphorylated β-catenin in sections adjoining (A) and (D) are 
shown in (B) and (E), respectively.  The total β-catenin staining in the adjacent normal 
tissues of the same patients is shown in (C) and (F).  Insets show higher 
magnifications where β-catenin is localized in the nuclei of intestinal-type and diffuse 
type gastric cancer cells, while it is found in the basolateral membrane of the adjacent 
normal epithelial cells.  Scale bars in (A-F) are 200 μm.  (G) Numbers and 
percentages of nuclear β-catenin-positive gastric cancer cases.   
 
Figure 2 
Generation of K19-Wnt1 transgenic mice.  (A) Construction of the transgenic vector. 
The artificial intron between the K19 promoter and Wnt1 cDNA is shown as a V-shape.  
Wnt1 cDNA and SV40 poly(A) fragments are shown as gray and black boxes, 
respectively.  Pm, PmeI;  N, NcoI; B, BamHI; Xb, XbaI.  (B) RT-PCR for Wnt1 mRNA in 
the gastric mucosa of the wild-type, K19-C2mE, K19-Wnt1 and K19-Wnt1/C2mE 
transgenic mice.  K19-C2mE and K19-Wnt1 transgenic mice.  GAPDH was used as 
an internal control.  (C) Immunoblotting of the gastric extracts from K19-Wnt1 
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transgenic lines (#1 through #5) for total (top) and unphosphorylated (activated form) 
β-catenin (middle) compared with that from wild-type mice (WT) and ApcΔ716 mouse 
normal intestine (N) and polyps (P).  β-Actin was used as an internal control (bottom).  
Note that all K19-Wnt 1 lines (#1 through #5) show an increased level of the 
unphosphorylated β-catenin compared with that of wild-type mice.  Two lines (#1 and 
#2) show comparable levels to that in the ApcΔ716 mouse intestinal polyps.  (D) 
Immunoblotting for COX-2 in the glandular stomach of the respective transgenic 
strains.   
 
Figure 3 
Gastric epithelial differentiation was suppressed by Wnt signaling.  (A) H&E staining of 
the isthmus of the glandular stomach, (B) in situ hybridization for TFF2, and (C) 
immunostaining for β-catenin using serial sections of (A).  The arrowheads indicate 
isthmal small cells with TFF2 expression and β-catenin accumulation (progenitor 
cells).  Scale bars in (A-C) are 100 μm.  (D) TFF2-expressing cells (asterisks) in the 
glandular stomach of the wild-type (left) and K19-Wnt1 (right) mice (in situ 
hybridization).  Histogram shows the mean number of TFF2-positive cells per gland 
(mean ± s.d.).  (E) Cells incorporated BrdU (asterisks) with 30 minute-labeling in the 
glandular stomach of the wild-type (left) and K19-Wnt1 (right) mice (immunostaining).  
Histogram shows the BrdU labeling index (mean ± s.d.).  (F) Cells labeled with Ki-67 
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(asterisks) in the glandular stomach of the wild-type (left) and K19-Wnt1 (right) mice 
(immunostaining).  Histogram shows the Ki-67 labeling index (mean ± s.d.).  Scale 
bars in (D-F) are 200 μm.  Note that the numbers of TFF2-positive cells, BrdU labeled 
cells, and Ki-67-stained cells all increased significantly in the K19-Wnt1 mouse 
glandular stomach compared with those in the wild-type mice. 
 
Figure 4 
Small preneoplastic lesions in the glandular stomach of K19-Wnt1 mice at 7 weeks 
(B) and 18 weeks of age (C), and control wild-type mice at 18 weeks of age (A).  
Arrows indicate small preneoplastic lesions.  Toluidine blue staining.  Scale bars in 
(A-C) are 0.5 mm.  (D) H&E staining of the preneoplastic lesions, (E) Ki-67 and (F) 
β-catenin immunostaining using serial sections of (D).  The open arrowheads in (D-F) 
indicate small undifferentiated epithelial cells with an increased proliferation and 
β-catenin accumulation.  Inset in (F) shows a higher magnification of β-catenin 
accumulated cells.  Scale bars in (D-F) are 100 μm. 
 
Figure 5 
Gastric tumors in K19-Wnt1/C2mE mice.  Macroscopic photographs (top) and H&E 
staining (bottom) of the glandular stomach of the wild-type (A), K19-Wnt1/C2mE (B), 
K19-Wnt1 (C) and K19-C2mE (D) mice at 30 weeks of age.  Arrowheads (white in top 
 28
Oshima, H. et al. 
and black in bottom panels) indicate the border between the glandular stomach and 
forestomach.  Small arrows in (C) point to the preneoplastic lesions.  Large arrows in 
(A) indicate dysplastic tumors with hyperemia in the K19-Wnt1/C2mE stomach.  No 
such tumors were found in either of the simple transgenic strains.  Scale bars in (A-D, 
bottom) are 2 mm.  (E) Histology of the K19-Wnt1/C2mE gastric tumors (H&E).  Serial 
sections of (E), immunostained for β-catenin (F) and Ki-67 (G).  Arrows in (E and F) 
indicate dysplastic epithelial cells with the nuclear accumulation of β-catenin.  The 
scale bars in (E-G) are 100 μm.  (H) in situ hybridization for TFF2 to detect SPEM cells 
(arrows) adjacent to the dysplastic tumors in the K19-Wnt1/C2mE mice at 30 weeks of 
age.  (I) The arrowheads point to the invasion of tumor epithelial cells into the smooth 
muscle layers (H&E).  Scale bar in (I) is 200 μm.  (J) The number of mice with invasive 
tumors in the K19-Wnt1/C2mE mice at 10, 20, 30 and 50 weeks of age.  (K) Incidence 
of dysplastic tumors in the respective mouse strains older than 20 weeks of age.   
 
Figure 6 
Immunostaining for macrophages using F4/80 antibody in the wild-type mouse 
stomach (A), K19-Wnt1/C2mE tumor (B) and K19-Wnt1 preneoplastic lesion (C).  
Heavy macrophage accumulation was found in the K19-Wnt1/C2mE mouse tumor.  
The arrows in (A) indicate sparsely scattered tissue macrophages in the normal 
stomach.  The arrowheads in (C) indicate the macrophages accumulated in the 
 29
Oshima, H. et al. 
preneoplastic lesion.  Scale bars in (A-C) are 100 μm.  Immunostaining for capillary 
vessels using anti-vWF antibody in the K19-Wnt1 stomach (D) and K19-Wnt1/C2mE 
tumor (E).  Scale bars in (D, E) are 100 μm.  (F) Relative microvessel density (MVD) to 
the wild-type level is shown (mean ± s.d.).  *, P < 0.05, versus wild-type mice.  +, P < 
0.05, versus K19-Wnt1 mice.   
 
Figure 7 
Chronological changes in gastric tumorigenesis in the K19-Wnt1/C2mE mice (A-H) 
and K19-C2mE mice (I-P) at 5, 10, 20 and 50 weeks of age.  H&E staining (A-D and 
I-L), and Alcian blue staining at pH2.5 of the serial sections (E-H and M-P).  Alcian 
blue staining in the wild-type mouse stomach (WT) is also shown (E: right).  The 
arrows indicate Alcian blue-positive metaplastic mucous cells.  Arrowhead in (E, right) 
indicates Alcian blue-positive normal mucous neck cells.  The dotted lines in (B, C, F, 
and G) indicate the border between the metaplastic and dysplastic (Dys) regions.  
Scale bars are 100 μm.  Both strains show mucous metaplasia after 5 weeks of age.  
However, dysplastic epithelial cells are found only in the K19-Wnt1/C2mE stomach 
after 10 weeks of age.  Dysplastic epithelial cells predominate the tumor tissues of the 
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The BrdU labeling index in the glandular stomach of the wild-type (green), K19-C2mE 
(gray) and K19-Wnt1/C2mE (black) mice at 5, 10, 20, and 50 weeks of age (mean ± 
s.d.).  *, P < 0.05, versus wild-type mice.  +, P < 0.05, versus K19-C2mE mice.  The 
BrdU indices in the K19-C2mE and K19-Wnt1/C2mE glandular stomach are 
significantly higher than those in the wild-type mice.  K19-Wnt1/C2mE mice show 
even higher proliferation rate than that in the K19-C2mE mice at 20 and 50 weeks of 
age. 
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